Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) CEO George K. N

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Free Report) CEO George K. Ng purchased 10,000 shares of Processa Pharmaceuticals stock in a transaction that occurred on Tuesday, January 30th. The stock was acquired at an average price of $2.70 per share, with a total value of $27,000.00. Following the transaction, the chief executive officer now owns […]

Related Keywords

, Walleye Capital , Securities Exchange Commission , Processa Pharmaceuticals Inc , Maxim Group , Processa Pharmaceuticals Trading Down , Renaissance Technologies , News Ratings For Processa Pharmaceuticals Daily , Processa Pharmaceuticals Company Profile , Nasdaq , Processa Pharmaceuticals , Raymond James Financial Services Advisors Inc , Hedge Funds Weigh In On Processa Pharmaceuticals , Sigma Securities , Dimensional Fund Advisors , Get Free Report , Exchange Commission , Pharmaceuticals Trading Down , Fund Advisors , James Financial Services Advisors , Processa Pharmaceuticals Daily , Nasdaq Pcsa , Hpcsa , Medical , Insider Trading , Nsider Trades , Tocks ,